These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25498484)

  • 1. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial.
    Roberts I; Prieto-Merino D; Manno D
    Crit Care; 2014 Dec; 18(6):685. PubMed ID: 25498484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
    Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
    Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
    Perel P; Prieto-Merino D; Shakur H; Roberts I
    Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
    Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
    Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
    Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
    West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
    ; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
    Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
    Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
    Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic drugs for acute traumatic injury.
    Ker K; Roberts I; Shakur H; Coats TJ
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
    Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
    BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of administering tranexamic acid to bleeding trauma patients using evidence from the CRASH-2 trial.
    Guerriero C; Cairns J; Perel P; Shakur H; Roberts I;
    PLoS One; 2011 May; 6(5):e18987. PubMed ID: 21559279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
    Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
    Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trauma and severe bleeding. Tranexamic acid within one hour to reduce mortality.
    Prescrire Int; 2013 Jul; 22(140):189-90. PubMed ID: 23951599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
    ; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S; Herrera J; Hunt B; Iribhogbe P; Izurieta M; Khamis H; Komolafe E; Marrero MA; Mejía-Mantilla J; Miranda J; Morales C; Olaomi O; Olldashi F; Perel P; Peto R; Ramana PV; Ravi RR; Yutthakasemsunt S
    Lancet; 2010 Jul; 376(9734):23-32. PubMed ID: 20554319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic acid for trauma: filling the 'GAP' in evidence.
    Mitra B; Mazur S; Cameron PA; Bernard S; Burns B; Smith A; Rashford S; Fitzgerald M; Smith K; Gruen RL;
    Emerg Med Australas; 2014 Apr; 26(2):194-7. PubMed ID: 24708011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tranexamic acid for trauma patients: a critical review of the literature.
    Cap AP; Baer DG; Orman JA; Aden J; Ryan K; Blackbourne LH
    J Trauma; 2011 Jul; 71(1 Suppl):S9-14. PubMed ID: 21795884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic Acid Update in Trauma.
    Ramirez RJ; Spinella PC; Bochicchio GV
    Crit Care Clin; 2017 Jan; 33(1):85-99. PubMed ID: 27894501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial.
    Brenner A; Afolabi A; Ahmad SM; Arribas M; Chaudhri R; Coats T; Cuzick J; Gilmore I; Hawkey C; Jairath V; Javaid K; Kayani A; Mutti M; Nadeem MA; Shakur-Still H; Stanworth S; Veitch A; Roberts I;
    Trials; 2019 Jul; 20(1):467. PubMed ID: 31362765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrinolytic drugs for acute traumatic injury.
    Roberts I; Shakur H; Ker K; Coats T;
    Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data.
    Nutbeam T; Roberts I; Weekes L; Shakur-Still H; Brenner A; Ageron FX
    Br J Anaesth; 2022 Aug; 129(2):191-199. PubMed ID: 35597623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.